Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

17.52 -0.09 (-0.48%)
Streaming Delayed Price Updated: 11:34 AM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theravance Biopharma, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield... 
Via Benzinga
News headline image
Here's Why Theravance Biopharma Stock Is Tanking Today ↗
The company's second clinical-trial flop in as many months isn't sitting well with investors. 
Via The Motley Fool
News headline image
Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings ↗
Toward the end of trading Tuesday, the Dow traded up 0.26% to 35,427.95 while the NASDAQ rose 0.50% to 15,018.26. The S&P also rose, gaining 0.25% to 4,490.82. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Vaccine Optimism Pushes S&P 500, Nasdaq to Fresh Intraday Highs ↗
This week is so far proving to be much better than the last one, as the three major indexes look to extend yesterday's gains. 
Via Talk Markets
Topics Stocks
News headline image
Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study ↗
Analysts have lowered the price target and downgraded Theravance Biopharma Inc (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is... 
Via Benzinga
News headline image
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide ↗
Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
What 10 Analyst Ratings Have To Say About Theravance Biopharma ↗
Theravance Biopharma (NASDAQ:TBPH) has observed the following analyst rati... 
Via Benzinga
News headline image
38 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates ↗
Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug? ↗
Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday. 
Via Investor's Business Daily
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday's morning trading, 20 companies set new 52-week lows. Noteables: The largest company in terms of market cap to set a new 52-week low was Campbell... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021 ↗
Upgrades Canaccord Genuity upgraded the previous rating for Precision Drilling Corp (NYSE: 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Benchmark cut the price target for JD.com, Inc. (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
News headline image
Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study ↗
Theravance Biopharma Inc's (NASDAQ: TBPH) Izencitinib, a "gut-selective" JAK inhibitor developed for ulcerative colitis and Crohn's disease, failed a... 
Via Benzinga
News headline image
Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript ↗
TBPH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Theravance Biopharma Q2 Earnings ↗
Shares of Theravance Biopharma (NASDAQ:TBPH) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 20.00% year over... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
News headline image
Know When To Hold 'Em, Know When To Fold 'Em ... ↗
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Before 10 a.m. ET Monday, 63 stocks made new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was PACCAR (NASDAQ:PCAR).... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
Earnings Scheduled For August 3, 2021 ↗
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... 
Via Benzinga
Topics Stocks
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
During the morning session on Thursday, 152 stocks hit new 52-week lows. Interesting Points: TotalEnergies (NYSE:TTE) was the biggest company by market cap to set a new 52... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... 
Via Benzinga
Topics Product Recall
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.